Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2. [electronic resource]
Producer: 20210125Description: 3943-3955 p. digitalISSN:- 1530-6860
- Animals
- Cell Line, Tumor
- Cell Survival -- drug effects
- Glucose -- metabolism
- Glycolysis -- drug effects
- Hexokinase -- metabolism
- Humans
- Immunohistochemistry
- Lactams -- pharmacology
- Lactic Acid -- metabolism
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Real-Time Polymerase Chain Reaction
- Surface Plasmon Resonance
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.